Source: EURLEX
Language: en
Format: md

Order of the General Court (Fifth Chamber) of 20 June 2018 –  
Unigroup v EUIPO — Pronova Laboratories (nailicin)

(Case T‑587/17)

(EU trade mark — Opposition proceedings — Application for EU word mark nailicin — Earlier Benelux word mark NAILCLIN — Relative ground for refusal — Copy of the certificate of registration of the earlier mark — Rule 19(2)(a)(ii) of Regulation (EC) No 2868/95 (now Article 7(2)(a)(ii) of Delegated Regulation (EU) 2017/1430) — Taking into account of a document submitted in conjunction with the notice of opposition — Rule 19(4) Regulation No 2868/95 (now Article 7(5) of Delegated Regulation 2017/1430) — Action manifestly lacking any foundation in law)

EU trade mark — Observations of third parties and opposition — Examination of the opposition — Facts and evidence not produced in support of the opposition within the period prescribed for that purpose — Interpretation of Rule 19, paragraph 4, of Regulation No 2868/95

(Commission Regulation No 2868/95, Art. 1, Rules 15(3), 18(1), 19(1), (2)(a)(ii), and (4) and 20(1))

(see paras 28, 30-32)

Re:

Action brought against the decision of the Fifth Board of Appeal of EUIPO of 9 June 2017 (Case R 2359/2016-5), relating to opposition proceedings between Pronova Laboratories and Unigroup.

Operative part

| 1. | The action is dismissed. |

| 2. | Unigroup ApS is ordered to bear its own costs and to pay those incurred by the European Union Intellectual Property Office (EUIPO) and by Pronova Laboratories BV. |

[Top](#document1)